Similar articles for PMID: 26974989

Year	Number of Results
1998	3
1999	3
2001	2
2002	1
2003	3
2004	2
2005	2
2006	1
2007	2
2008	2
2009	2
2011	4
2012	4
2013	2
2014	3
2015	10
2016	41
2017	16
2018	7
2019	7
2020	9
2021	15
2022	4
2024	0

1

Interpreting SPRINT: How low should you go?

Thomas G, Nally JV, Pohl MA. Thomas G, et al. Cleve Clin J Med. 2016 Mar;83(3):187-95. doi: 10.3949/ccjm.83a.15175. Cleve Clin J Med. 2016. PMID: 26974989 Free article. Review.

2

Impact of the SPRINT Trial on Hypertension Management.

Ghazi L, Oparil S. Ghazi L, et al. Annu Rev Med. 2018 Jan 29;69:81-95. doi: 10.1146/annurev-med-050416-024516. Annu Rev Med. 2018. PMID: 29414255 Review.

3

Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.

Zanchetti A, Thomopoulos C, Parati G. Zanchetti A, et al. Circ Res. 2015 Mar 13;116(6):1058-73. doi: 10.1161/CIRCRESAHA.116.303641. Circ Res. 2015. PMID: 25767290 Free article. Review.

4

Should blood pressure goal be individualized in hypertensive patients?

Yannoutsos A, Kheder-Elfekih R, Halimi JM, Safar ME, Blacher J. Yannoutsos A, et al. Pharmacol Res. 2017 Apr;118:53-63. doi: 10.1016/j.phrs.2016.11.037. Epub 2016 Dec 2. Pharmacol Res. 2017. PMID: 27919826 Review.

5

SPRINT Revisited: Updated Results and Implications.

Wright JT Jr, Whelton PK, Johnson KC, Snyder JK, Reboussin DM, Cushman WC, Williamson JD, Pajewski NM, Cheung AK, Lewis CE, Oparil S, Rocco MV, Beddhu S, Fine LJ, Cutler JA, Ambrosius WT, Rahman M, Still CH, Chen Z, Tatsuoka C; SPRINT Research Group. Wright JT Jr, et al. Hypertension. 2021 Dec;78(6):1701-1710. doi: 10.1161/HYPERTENSIONAHA.121.17682. Epub 2021 Nov 10. Hypertension. 2021. PMID: 34757768 Free PMC article. Review.

6

Current and Future Treatment of Hypertension in the SPRINT Era.

Phillips RA. Phillips RA. Methodist Debakey Cardiovasc J. 2015 Oct-Dec;11(4):206-13. doi: 10.14797/mdcj-11-4-206. Methodist Debakey Cardiovasc J. 2015. PMID: 27057288 Free PMC article. Review.

7

In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?

Tyson CC, Coffman TM. Tyson CC, et al. Nephron. 2017;135(4):287-290. doi: 10.1159/000455130. Epub 2017 Feb 4. Nephron. 2017. PMID: 28161697 Free article. Clinical Trial.

8

BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?

Bhatt H, Ghazi L, Calhoun D, Oparil S. Bhatt H, et al. Curr Cardiol Rep. 2016 Oct;18(10):98. doi: 10.1007/s11886-016-0775-0. Curr Cardiol Rep. 2016. PMID: 27566331 Review.

9

SPRINT: What Remains Unanswered and Where Do We Go From Here?

Jones DW, Weatherly L, Hall JE. Jones DW, et al. Hypertension. 2016 Feb;67(2):261-2. doi: 10.1161/HYPERTENSIONAHA.115.06723. Epub 2015 Nov 9. Hypertension. 2016. PMID: 26553235 Review. No abstract available.

10

How Low Can You Go? What Can We Take From the SPRINT Trial.

Hayes W, Clem J. Hayes W, et al. S D Med. 2016 Jan;69(1):34. S D Med. 2016. PMID: 26882581 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

132 results

Results by year